Document Detail


Blood pressure variability and risk of new-onset atrial fibrillation: a systematic review of randomized trials of antihypertensive drugs.
MedLine Citation:
PMID:  20651263     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND PURPOSE: Increased visit-to-visit variability in blood pressure (BP) is a powerful risk factor for stroke, but the mechanism is uncertain. We hypothesized that BP variability might affect the risk of new atrial fibrillation (AF).
METHODS: We did a systematic review of large randomized controlled trials reporting new-onset AF by treatment allocation, excluding studies in heart failure and acute myocardial infarction. Estimates of the risk of new AF by treatment allocation were related to effects of treatment on group variability in BP.
RESULTS: Of 94 eligible randomized controlled trials, 14 reported rates of new AF. Although there was considerable heterogeneity between trials in effects of treatment on variance ratio (P<0.0001), lower variance ratio was unrelated to new-onset AF either on meta-analysis (OR=1.02; 95% CI 0.90 to 1.15; 125 878 patients; 13 comparisons) or on metaregression (log OR versus log variance ratio of systolic blood pressure r(2)=0.109, P=0.270). Angiotensin receptor blockers tended to reduce new-onset AF (OR 0.85; 95% CI 0.71 to 1.01; P=0.067; 4 trials; 47 482 patients) with significant reductions in 2 individual trials but had no consistent reduction on variability in BP.
CONCLUSIONS: Effects of randomized treatment on variability in BP are unrelated to risk of new-onset AF, suggesting that other mechanisms account for the link between variability and stroke risk. However, a lower incidence of AF in patients randomized to angiotensin receptor blockers may explain reductions in stroke risk in some trials.
Authors:
Alastair J S Webb; Peter M Rothwell
Related Documents :
20848323 - Establishing targets for hypertension control in patients with comorbidities.
17446953 - A survey of hypertensive practices at two community health centres in cape town.
9269143 - Color doppler echocardiographic evaluation of tricuspid regurgitation and systolic pulm...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2010-07-22
Journal Detail:
Title:  Stroke; a journal of cerebral circulation     Volume:  41     ISSN:  1524-4628     ISO Abbreviation:  Stroke     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-31     Completed Date:  2010-09-22     Revised Date:  2011-11-01    
Medline Journal Info:
Nlm Unique ID:  0235266     Medline TA:  Stroke     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2091-3     Citation Subset:  IM    
Affiliation:
Stroke Prevention Research Unit, Department of Clinical Neurology, John Radcliffe Hospital, Oxford OX39DU, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / therapeutic use*
Atrial Fibrillation / epidemiology*
Blood Pressure / drug effects,  physiology*
Humans
Hypertension / drug therapy*
Randomized Controlled Trials as Topic
Risk
Risk Assessment
Chemical
Reg. No./Substance:
0/Antihypertensive Agents
Comments/Corrections
Erratum In:
Stroke. 2011 Oct;42(10):e569

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical Prac...
Next Document:  Reflux Esophagitis and the Risk of Stroke in Young Adults. A 1-Year Population-Based Follow-Up Study...